Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details

Raymond James initiated coverage on Revolution Medicines Inc RVMD, noting that the October readout of RMC-6236 was compelling compared to historical SoC.…

Related Keywords

Raymond James ,Revolution Medicines Inc ,News ,Ggregator ,Reaking News ,Uration ,Media ,